Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by rankininleton Oct 14, 2021 5:56pm
220 Views
Post# 34007124

Deep, context issue - see below

Deep, context issue - see belowThanks for lawyer quote.  I not agree that his comment about MEDV triple patient increase  means sales increase 3x starting at some point in early August. The lawyer was responding to complaints about service failures at two specific Collection Sites.  He not intend for the info to be used other than to point out that growing pains existed due to growth and the company is improving systems etc ... to respond.  My take still remains that Q3 sales are ~1.0 million US per week hence 12 mil for Q3.  That is the July run-rate applied to Aug and Sept assuming 4 weeks per month.  Any number above that, not coming from MEDV seems rich or hype.  Because covid testing in the MEDV format is not permanent revenue I not comfortable saying MEDV has ~50 million in annual sales.  Is MEDV a buy at .045? I not sure. I will pass for now as sentiment sucks. GLTA
<< Previous
Bullboard Posts
Next >>